PTGS2 and gastric cancer: Collectively, these findings underscore the potential therapeutic efficacy of Hairyvein Agrimonia in antagonizing gastric cancer progression, potentially mediated through its modulation of PTGS2 activity and its interplay with key molecular pathways implicated in disease pathogenesis.